Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
Apply
Risvutatug Rezetecan
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step